Silexion Therapeutics Corp (SLXN)
NASDAQ: SLXN · Real-Time Price · USD
1.960
+0.230 (13.29%)
At close: Mar 9, 2026, 4:00 PM EDT
1.900
-0.060 (-3.06%)
After-hours: Mar 9, 2026, 7:13 PM EDT
Silexion Therapeutics Market Cap
Silexion Therapeutics has a market cap or net worth of $6.13 million as of March 9, 2026. Its market cap has decreased by -18.17% in one year.
Market Cap
6.13M
Enterprise Value
-1.68M
1-Year Change
-18.17%
Ranking
Category
Stock Price
$1.96
Market Cap Chart
Since April 7, 2021, Silexion Therapeutics's market cap has decreased from $148.55M to $6.13M, a decrease of -95.87%. That is a compound annual growth rate of -47.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 5.41M | -9.90% |
| Dec 31, 2025 | 6.00M | 86.31% |
| Dec 31, 2024 | 3.22M | -92.33% |
| Dec 21, 2023 | 41.99M | -71.93% |
| Dec 30, 2022 | 149.59M | 4.03% |
| Dec 31, 2021 | 143.80M | -3.20% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Purple Biotech | 6.02M |
| Aspire Biopharma Holdings | 5.83M |
| Psyence Biomedical | 5.76M |
| Quince Therapeutics | 5.70M |
| Lunai Bioworks | 5.62M |
| Cyclerion Therapeutics | 5.37M |
| Xenetic Biosciences | 5.25M |
| MetaVia | 4.97M |